These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
941 related items for PubMed ID: 16216651
1. Resistance to antibiotics: are we in the post-antibiotic era? Alanis AJ. Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651 [Abstract] [Full Text] [Related]
5. New antimicrobial agents for the treatment of bacterial infections in cancer patients. Rolston KV. Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253 [Abstract] [Full Text] [Related]
6. Antibiotic development: a victim of market forces? Tillotson GS. IDrugs; 2008 May; 11(5):340-6. PubMed ID: 18465675 [Abstract] [Full Text] [Related]
7. Societal costs versus savings from wild-card patent extension legislation to spur critically needed antibiotic development. Spellberg B, Miller LG, Kuo MN, Bradley J, Scheld WM, Edwards JE. Infection; 2007 Jun; 35(3):167-74. PubMed ID: 17565458 [Abstract] [Full Text] [Related]
8. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance. Werarak P, Kiratisin P, Thamlikitkul V. J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567 [Abstract] [Full Text] [Related]
15. Reducing antimicrobial resistance through appropriate antibiotic usage in Singapore. Hsu LY, Kwa AL, Lye DC, Chlebicki MP, Tan TY, Ling ML, Wong SY, Goh LG. Singapore Med J; 2008 Oct; 49(10):749-55. PubMed ID: 18946605 [Abstract] [Full Text] [Related]
16. The issue of antimicrobial resistance in human medicine. Beović B. Int J Food Microbiol; 2006 Dec 01; 112(3):280-7. PubMed ID: 16815582 [Abstract] [Full Text] [Related]
17. Epidemiological factors influencing the emergence of antimicrobial resistance. Cohen ML. Ciba Found Symp; 1997 Dec 01; 207():223-31; discussion 231-7. PubMed ID: 9189644 [Abstract] [Full Text] [Related]
18. Antimicrobial stewardship: bridging the gap between quality care and cost. Goff DA. Curr Opin Infect Dis; 2011 Feb 01; 24 Suppl 1():S11-20. PubMed ID: 21200180 [Abstract] [Full Text] [Related]
19. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. Lynch AS. Biochem Pharmacol; 2006 Mar 30; 71(7):949-56. PubMed ID: 16290174 [Abstract] [Full Text] [Related]
20. Future antibiotics scenarios: is the tide starting to turn? Theuretzbacher U. Int J Antimicrob Agents; 2009 Jul 30; 34(1):15-20. PubMed ID: 19342202 [Abstract] [Full Text] [Related] Page: [Next] [New Search]